User login
Water safety: Drowning isn’t the only concern
References
1. CDC Childhood Injury Report: Patterns of Unintentional Injuries among 0-19 Year Olds in the United States, 2000-2006. Centers for Disease Control and Prevention Web site. https://www.cdc.gov/safechild/pdf/cdc-childhoodinjury.pdf. Accessed June 26, 2019.
2. World Health Organization. Global Report on Drowning: Preventing a Leading Killer. https://apps.who.int/iris/bitstream/handle/10665/143893/9789241564786_eng.pdf;jsessionid=0B51AAEB51E29A603A0CABB41FCD96B5?sequence=1. Accessed June 26, 2019.
3. Vanden Esschert K, Haileyesus T, Tarrier AL, et al. Pool chemical injuries in public and residential settings—United States, 2008–2017, and New York, 2018. MMWR Morb Mortal Wkly Rep. 2019;68:433–438.
4. Healthy Swimming. Centers for Disease Control and Prevention Web site. https://www.cdc.gov/healthywater/swimming/index.html. Accessed June 26, 2019.
References
1. CDC Childhood Injury Report: Patterns of Unintentional Injuries among 0-19 Year Olds in the United States, 2000-2006. Centers for Disease Control and Prevention Web site. https://www.cdc.gov/safechild/pdf/cdc-childhoodinjury.pdf. Accessed June 26, 2019.
2. World Health Organization. Global Report on Drowning: Preventing a Leading Killer. https://apps.who.int/iris/bitstream/handle/10665/143893/9789241564786_eng.pdf;jsessionid=0B51AAEB51E29A603A0CABB41FCD96B5?sequence=1. Accessed June 26, 2019.
3. Vanden Esschert K, Haileyesus T, Tarrier AL, et al. Pool chemical injuries in public and residential settings—United States, 2008–2017, and New York, 2018. MMWR Morb Mortal Wkly Rep. 2019;68:433–438.
4. Healthy Swimming. Centers for Disease Control and Prevention Web site. https://www.cdc.gov/healthywater/swimming/index.html. Accessed June 26, 2019.
References
1. CDC Childhood Injury Report: Patterns of Unintentional Injuries among 0-19 Year Olds in the United States, 2000-2006. Centers for Disease Control and Prevention Web site. https://www.cdc.gov/safechild/pdf/cdc-childhoodinjury.pdf. Accessed June 26, 2019.
2. World Health Organization. Global Report on Drowning: Preventing a Leading Killer. https://apps.who.int/iris/bitstream/handle/10665/143893/9789241564786_eng.pdf;jsessionid=0B51AAEB51E29A603A0CABB41FCD96B5?sequence=1. Accessed June 26, 2019.
3. Vanden Esschert K, Haileyesus T, Tarrier AL, et al. Pool chemical injuries in public and residential settings—United States, 2008–2017, and New York, 2018. MMWR Morb Mortal Wkly Rep. 2019;68:433–438.
4. Healthy Swimming. Centers for Disease Control and Prevention Web site. https://www.cdc.gov/healthywater/swimming/index.html. Accessed June 26, 2019.
STIs may be overlooked if you fail to ask this question
Reference
Johnson Jones ML, Chapin-Bardales J, Bizune D. Extragenital chlamydia and gonorrhea among community venue – attending men who have sex with men – Five cities, United States, 2017. MMWR Morb Mortal Wkly Rep. 2019;68:321-325. https://www.cdc.gov/mmwr/volumes/68/wr/mm6814a1.htm?s_cid=mm6814a1_w. Accessed May 23, 2019.
Reference
Johnson Jones ML, Chapin-Bardales J, Bizune D. Extragenital chlamydia and gonorrhea among community venue – attending men who have sex with men – Five cities, United States, 2017. MMWR Morb Mortal Wkly Rep. 2019;68:321-325. https://www.cdc.gov/mmwr/volumes/68/wr/mm6814a1.htm?s_cid=mm6814a1_w. Accessed May 23, 2019.
Reference
Johnson Jones ML, Chapin-Bardales J, Bizune D. Extragenital chlamydia and gonorrhea among community venue – attending men who have sex with men – Five cities, United States, 2017. MMWR Morb Mortal Wkly Rep. 2019;68:321-325. https://www.cdc.gov/mmwr/volumes/68/wr/mm6814a1.htm?s_cid=mm6814a1_w. Accessed May 23, 2019.
Are you offering vaccines to adults for these 5 conditions?
References
1. Grohskopf LA, Sokolow LZ, Broder KR, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices—United States, 2018-19 influenza season. MMWR Recomm Rep. 2018;67:1-20.
2. Liang JL, Tiwari T, Moro P, et al. Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2018;67:1-44.
3. Dooling KL, Guo A, Patel M, et al. Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines. MMWR Morb Mortal Wkly Rep. 2018;67:103-108.
4. Kobayashi M, Bennett NM, Gierke R, et al. Intervals between PCV13 and PPSV23 vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2015;64;944-947.
5. Meites E, Kempe A, Markowitz LE. Use of a 2-dose schedule for human papillomavirus vaccination—updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2016;65:1405-1408.
6. Adult immunization schedule. Centers for Disease Control and Prevention website. https://www.cdc.gov/vaccines/schedules/hcp/imz/adult.html. Reviewed February 5, 2019. Accessed April 23, 2019.
References
1. Grohskopf LA, Sokolow LZ, Broder KR, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices—United States, 2018-19 influenza season. MMWR Recomm Rep. 2018;67:1-20.
2. Liang JL, Tiwari T, Moro P, et al. Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2018;67:1-44.
3. Dooling KL, Guo A, Patel M, et al. Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines. MMWR Morb Mortal Wkly Rep. 2018;67:103-108.
4. Kobayashi M, Bennett NM, Gierke R, et al. Intervals between PCV13 and PPSV23 vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2015;64;944-947.
5. Meites E, Kempe A, Markowitz LE. Use of a 2-dose schedule for human papillomavirus vaccination—updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2016;65:1405-1408.
6. Adult immunization schedule. Centers for Disease Control and Prevention website. https://www.cdc.gov/vaccines/schedules/hcp/imz/adult.html. Reviewed February 5, 2019. Accessed April 23, 2019.
References
1. Grohskopf LA, Sokolow LZ, Broder KR, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices—United States, 2018-19 influenza season. MMWR Recomm Rep. 2018;67:1-20.
2. Liang JL, Tiwari T, Moro P, et al. Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2018;67:1-44.
3. Dooling KL, Guo A, Patel M, et al. Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines. MMWR Morb Mortal Wkly Rep. 2018;67:103-108.
4. Kobayashi M, Bennett NM, Gierke R, et al. Intervals between PCV13 and PPSV23 vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2015;64;944-947.
5. Meites E, Kempe A, Markowitz LE. Use of a 2-dose schedule for human papillomavirus vaccination—updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2016;65:1405-1408.
6. Adult immunization schedule. Centers for Disease Control and Prevention website. https://www.cdc.gov/vaccines/schedules/hcp/imz/adult.html. Reviewed February 5, 2019. Accessed April 23, 2019.
The 2018 AHA/ACC cholesterol guidelines: What’s changed?
References
1. Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A report of The American College of Cardiology Foundation/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018 Nov 8. doi: 10.1016/j.jacc.2018.11.003. [Epub ahead of print].
2. Alenghat FJ, Davis AM. Management of blood cholesterol. JAMA. 2019;321:800-801.
3. Fanaroff AC, Califf RM, Windecker S, et al. Levels of evidence supporting American College of Cardiology/American Heart Association and European Society of Cardiology Guidelines, 2008-2018. JAMA. 2019;321:1069-1080. [ ]
4. US Preventive Services Task Force. Cardiovascular disease: risk assessment with nontraditional risk factors. July 2018. https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/cardiovascular-disease-screening-using-nontraditional-risk-assessment. Accessed March 26, 2019.
5. American Academy of Family Practitioners. Clinical Practice Guideline: Cholesterol. February 2019. https://www.aafp.org/patient-care/clinical-recommendations/all/cholesterol.html. Accessed March 26, 2019.
References
1. Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A report of The American College of Cardiology Foundation/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018 Nov 8. doi: 10.1016/j.jacc.2018.11.003. [Epub ahead of print].
2. Alenghat FJ, Davis AM. Management of blood cholesterol. JAMA. 2019;321:800-801.
3. Fanaroff AC, Califf RM, Windecker S, et al. Levels of evidence supporting American College of Cardiology/American Heart Association and European Society of Cardiology Guidelines, 2008-2018. JAMA. 2019;321:1069-1080. [ ]
4. US Preventive Services Task Force. Cardiovascular disease: risk assessment with nontraditional risk factors. July 2018. https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/cardiovascular-disease-screening-using-nontraditional-risk-assessment. Accessed March 26, 2019.
5. American Academy of Family Practitioners. Clinical Practice Guideline: Cholesterol. February 2019. https://www.aafp.org/patient-care/clinical-recommendations/all/cholesterol.html. Accessed March 26, 2019.
References
1. Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A report of The American College of Cardiology Foundation/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018 Nov 8. doi: 10.1016/j.jacc.2018.11.003. [Epub ahead of print].
2. Alenghat FJ, Davis AM. Management of blood cholesterol. JAMA. 2019;321:800-801.
3. Fanaroff AC, Califf RM, Windecker S, et al. Levels of evidence supporting American College of Cardiology/American Heart Association and European Society of Cardiology Guidelines, 2008-2018. JAMA. 2019;321:1069-1080. [ ]
4. US Preventive Services Task Force. Cardiovascular disease: risk assessment with nontraditional risk factors. July 2018. https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/cardiovascular-disease-screening-using-nontraditional-risk-assessment. Accessed March 26, 2019.
5. American Academy of Family Practitioners. Clinical Practice Guideline: Cholesterol. February 2019. https://www.aafp.org/patient-care/clinical-recommendations/all/cholesterol.html. Accessed March 26, 2019.
Don’t overlook this step in combatting the rise in STIs
Resources
1. Kuehn BM. A proactive approach needed to combat rising STIs. JAMA. 2019;321:330-332.
2. Screening Recommendations and Considerations Referenced in Treatment Guidelines and Original Sources. Centers for Disease Control and Prevention. https://www.cdc.gov/std/tg2015/screening-recommendations.htm. Updated June 4, 2015. Accessed February 27, 2019.
3. STD Clinical Consultation Network. National STD Curriculum. https://www.std.uw.edu/page/site/clinical-consultation. Accessed February 27, 2019.
4. National STD Curriculum. https://www.std.uw.edu/. Accessed February 27, 2019.
5. Sexually Transmitted Disease Surveillance 2017. Syphilis. Centers for Disease Control and Prevention. https://www.cdc.gov/std/stats17/syphilis.htm. Reviewed July 24, 2018. Accessed February 27, 2019.
Resources
1. Kuehn BM. A proactive approach needed to combat rising STIs. JAMA. 2019;321:330-332.
2. Screening Recommendations and Considerations Referenced in Treatment Guidelines and Original Sources. Centers for Disease Control and Prevention. https://www.cdc.gov/std/tg2015/screening-recommendations.htm. Updated June 4, 2015. Accessed February 27, 2019.
3. STD Clinical Consultation Network. National STD Curriculum. https://www.std.uw.edu/page/site/clinical-consultation. Accessed February 27, 2019.
4. National STD Curriculum. https://www.std.uw.edu/. Accessed February 27, 2019.
5. Sexually Transmitted Disease Surveillance 2017. Syphilis. Centers for Disease Control and Prevention. https://www.cdc.gov/std/stats17/syphilis.htm. Reviewed July 24, 2018. Accessed February 27, 2019.
Resources
1. Kuehn BM. A proactive approach needed to combat rising STIs. JAMA. 2019;321:330-332.
2. Screening Recommendations and Considerations Referenced in Treatment Guidelines and Original Sources. Centers for Disease Control and Prevention. https://www.cdc.gov/std/tg2015/screening-recommendations.htm. Updated June 4, 2015. Accessed February 27, 2019.
3. STD Clinical Consultation Network. National STD Curriculum. https://www.std.uw.edu/page/site/clinical-consultation. Accessed February 27, 2019.
4. National STD Curriculum. https://www.std.uw.edu/. Accessed February 27, 2019.
5. Sexually Transmitted Disease Surveillance 2017. Syphilis. Centers for Disease Control and Prevention. https://www.cdc.gov/std/stats17/syphilis.htm. Reviewed July 24, 2018. Accessed February 27, 2019.
Flu activity & measles outbreaks: Where we stand, steps we can take
Resources
Measles (Robeola). Centers for Disease Control and Prevention Web site. https://www.cdc.gov/measles/index.html. Updated January 28, 2019. Accessed January 31, 2019.
Influenza (Flu). Centers for Disease Control and Prevention Web site. https://www.cdc.gov/flu/index.htm. Updated January 25, 2019. Accessed January 31, 2019.
Resources
Measles (Robeola). Centers for Disease Control and Prevention Web site. https://www.cdc.gov/measles/index.html. Updated January 28, 2019. Accessed January 31, 2019.
Influenza (Flu). Centers for Disease Control and Prevention Web site. https://www.cdc.gov/flu/index.htm. Updated January 25, 2019. Accessed January 31, 2019.
Resources
Measles (Robeola). Centers for Disease Control and Prevention Web site. https://www.cdc.gov/measles/index.html. Updated January 28, 2019. Accessed January 31, 2019.
Influenza (Flu). Centers for Disease Control and Prevention Web site. https://www.cdc.gov/flu/index.htm. Updated January 25, 2019. Accessed January 31, 2019.
Aspirin as CVD prevention in seniors? Think twice
Resources
US Preventive Services Task Force. Final recommendation statement: Aspirin use to prevent cardiovascular disease and colorectal cancer: preventive medication.
https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/aspirin-to-prevent-cardiovascular-disease-and-cancer.
Published April 2016. Accessed September 14, 2018.
McNeil JJ, Woods RL, Nelson MR, et al. Effect of aspirin on disability-free survival in the healthy elderly. 2018;379:1499-1508.
https://www.nejm.org/doi/full/10.1056/NEJMoa1800722. Accessed November 7, 2018.
McNeil JJ, Nelson MR, Woods JE, et al. Effect of aspirin on all-cause mortality in the healthy elderly. 2018;379:1519-1528.
https://www.nejm.org/doi/full/10.1056/NEJMoa1803955. Accessed November 7, 2018.
Resources
US Preventive Services Task Force. Final recommendation statement: Aspirin use to prevent cardiovascular disease and colorectal cancer: preventive medication.
https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/aspirin-to-prevent-cardiovascular-disease-and-cancer.
Published April 2016. Accessed September 14, 2018.
McNeil JJ, Woods RL, Nelson MR, et al. Effect of aspirin on disability-free survival in the healthy elderly. 2018;379:1499-1508.
https://www.nejm.org/doi/full/10.1056/NEJMoa1800722. Accessed November 7, 2018.
McNeil JJ, Nelson MR, Woods JE, et al. Effect of aspirin on all-cause mortality in the healthy elderly. 2018;379:1519-1528.
https://www.nejm.org/doi/full/10.1056/NEJMoa1803955. Accessed November 7, 2018.
Resources
US Preventive Services Task Force. Final recommendation statement: Aspirin use to prevent cardiovascular disease and colorectal cancer: preventive medication.
https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/aspirin-to-prevent-cardiovascular-disease-and-cancer.
Published April 2016. Accessed September 14, 2018.
McNeil JJ, Woods RL, Nelson MR, et al. Effect of aspirin on disability-free survival in the healthy elderly. 2018;379:1499-1508.
https://www.nejm.org/doi/full/10.1056/NEJMoa1800722. Accessed November 7, 2018.
McNeil JJ, Nelson MR, Woods JE, et al. Effect of aspirin on all-cause mortality in the healthy elderly. 2018;379:1519-1528.
https://www.nejm.org/doi/full/10.1056/NEJMoa1803955. Accessed November 7, 2018.
ECG to screen asymptomatic adults? Not so fast, says USPSTF
Resources
US Preventive Services Task Force. Final recommendation statement: Cardiovascular disease risk: screening with electrocardiography.
https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/cardiovascular-disease-risk-screening-with-electrocardiography. Published June 2018. Accessed October 23, 2018.
US Preventive Services Task Force. Final recommendation statement: Atrial fibrillation: screening with electrocardiography.
https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/atrial-fibrillation-screening-with-electrocardiography. Published August 2018. Accessed October 23, 2018.
Resources
US Preventive Services Task Force. Final recommendation statement: Cardiovascular disease risk: screening with electrocardiography.
https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/cardiovascular-disease-risk-screening-with-electrocardiography. Published June 2018. Accessed October 23, 2018.
US Preventive Services Task Force. Final recommendation statement: Atrial fibrillation: screening with electrocardiography.
https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/atrial-fibrillation-screening-with-electrocardiography. Published August 2018. Accessed October 23, 2018.
Resources
US Preventive Services Task Force. Final recommendation statement: Cardiovascular disease risk: screening with electrocardiography.
https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/cardiovascular-disease-risk-screening-with-electrocardiography. Published June 2018. Accessed October 23, 2018.
US Preventive Services Task Force. Final recommendation statement: Atrial fibrillation: screening with electrocardiography.
https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/atrial-fibrillation-screening-with-electrocardiography. Published August 2018. Accessed October 23, 2018.
Cervical cancer: Who should you screen?
Resource
US Preventive Services Task Force. Screening for cervical cancer: US Preventive Services Task Force recommendation statement. JAMA. 2018;320:674-686. https://jamanetwork.com/journals/jama/fullarticle/2697704. Accessed September 14, 2018.
Resource
US Preventive Services Task Force. Screening for cervical cancer: US Preventive Services Task Force recommendation statement. JAMA. 2018;320:674-686. https://jamanetwork.com/journals/jama/fullarticle/2697704. Accessed September 14, 2018.
Resource
US Preventive Services Task Force. Screening for cervical cancer: US Preventive Services Task Force recommendation statement. JAMA. 2018;320:674-686. https://jamanetwork.com/journals/jama/fullarticle/2697704. Accessed September 14, 2018.
DTC test for BRCA mutations: What to tell patients who inquire
Resources
US Food & Drug Administration. FDA authorizes, with special controls, direct-to-consumer test that reports three mutations in the BRCA breast cancer genes. March 6, 2018. Available at: https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm599560.htm. Accessed August 8, 2018.
US Preventive Services Task Force. Final recommendation statement: BRCA-related cancer: risk assessment, genetic counseling, and genetic testing. Available at:
https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing. Accessed August 8, 2018.
Resources
US Food & Drug Administration. FDA authorizes, with special controls, direct-to-consumer test that reports three mutations in the BRCA breast cancer genes. March 6, 2018. Available at: https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm599560.htm. Accessed August 8, 2018.
US Preventive Services Task Force. Final recommendation statement: BRCA-related cancer: risk assessment, genetic counseling, and genetic testing. Available at:
https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing. Accessed August 8, 2018.
Resources
US Food & Drug Administration. FDA authorizes, with special controls, direct-to-consumer test that reports three mutations in the BRCA breast cancer genes. March 6, 2018. Available at: https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm599560.htm. Accessed August 8, 2018.
US Preventive Services Task Force. Final recommendation statement: BRCA-related cancer: risk assessment, genetic counseling, and genetic testing. Available at:
https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing. Accessed August 8, 2018.